Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.790
-0.010 (-0.56%)
At close: Dec 1, 2025, 4:00 PM EST
1.700
-0.090 (-5.03%)
After-hours: Dec 1, 2025, 5:59 PM EST
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $212.69 million as of December 1, 2025. Its market cap has increased by 115.45% in one year.
Market Cap
212.69M
Enterprise Value
205.55M
1-Year Change
115.45%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $212.69M, an increase of 45.72%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 212.69M | 180.06% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |